Labcorp price target raised to $277 from $261 at Baird

Baird raised the firm’s price target on Labcorp to $277 from $261 and keeps an Outperform rating on the shares. The firm said the company is delivering solid core results in LCD and BLS Central Lab, while BLS ED appears primed to rebound RoY. Invitae negativity was overdone and update well received.